Triple-action diabetes jab shown to reduce blood sugar and body weight – The Guardian
& more related News Here
Time Room
Triple-action diabetes jab shown to reduce blood sugar and body weightGuardian
Eli Lilly says next-generation obesity drug curbs sleep apnea, among other benefitsreuters
ADA: Lilly unveils impressive triple-G efficacy in patients with obesity, diabetesfierce biotech
Lilly’s triple agonist, retreutide, significantly improved weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential in the treatment of obesity and its complications.investors.lilly.com
A new wave of weight loss therapies aim to be better than today’s GLP-1smarket Watch